These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36237519)

  • 21. Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis.
    Zhao L; Wang T; Guo C; Zhou L; Han P; Wang C; Ma Y; Wang J; Gao M; Li J
    Hepatol Int; 2022 Aug; 16(4):936-943. PubMed ID: 35727500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment.
    Agarwal A; Pathak P; Gupta S; Kumar R; Shalimar
    Indian J Gastroenterol; 2021 Dec; 40(6):590-597. PubMed ID: 33991311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Yan Y; Xing X; Wang X; Yang L
    Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spleen Thickness Plus Platelets Can Effectively and Safely Screen for High-Risk Varices in Cirrhosis Patients.
    Zhang F; Zhou Y; Li X; Wang C; Liu J; Li S; Zhang S; Luo W; Zhao L; Li J
    Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37891985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extending and validating the Baveno VI criteria for the exclusion of high-risk varices.
    Barbulescu A; Ratiu I; Sporea I; Lungeanu D; Lupusoru R; Miutescu B; Danila M; Popescu A; Sirli R
    Med Ultrason; 2021 Aug; 23(3):265-270. PubMed ID: 33657192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
    Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
    Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
    J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A strategy for varices screening based on acoustic radiation force impulse combined with platelet (CHESS2001): An alternative of Baveno VI criteria.
    Huang Y; Zhao L; He R; Li S; Liu C; Qi X; Li J
    Hepatol Commun; 2022 Nov; 6(11):3154-3162. PubMed ID: 36121707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
    Cho YS; Kim Y; Sohn JH
    Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study.
    Wong YJ; Kew GS; Tan PS; Chen Z; Putera M; Yip WA; Ang TL; Fock KM; Lee GH; Hsiang J; Huang DQ; Kwek A; Muthiah MD; Kumar R; Tan M; Tan J; Thurairajah PH; Teo EK; Tai BC; Lim SG
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101598. PubMed ID: 33780835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of esophageal varices by liver stiffness and serum biomarkers in virus-related compensated advanced chronic liver disease.
    Zoughlami A; Serero J; Congly S; Zhao I; Zhu J; Ramji A; Cooper C; Wong P; Bailey R; Coffin CS; Sebastiani G;
    Can Liver J; 2023 Oct; 6(3):332-346. PubMed ID: 38020192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.
    Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W
    Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38502095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.
    Calès P; Ravaioli F; Berger A; Farcau O; Festi D; Stefanescu H; Vitellius C; Nahon P; Bureau C; Ganne-Carriè N; Berzigotti A; de Ledinghen V; Petta S
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101925. PubMed ID: 35470108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are we missing varices by implementing Baveno-VI recommendation of not screening patients with Compensated Advanced Chronic Liver Disease?
    Ali FS; Bader N; Zuberi BF; Rasheed T
    Pak J Med Sci; 2022; 38(1):1-8. PubMed ID: 35035392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.